Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?
Stent thrombosis is a catastrophic complication of percutaneous coronary intervention (PCI) and is associated with a mortality of 25 to 40%. The perception that stent thrombosis is very low in all patients has resulted in a lack of adherence to professional guidelines. New data to identify patients...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
South African Heart Association
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/30784cb229da45439b3270debb1493bc |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|